SCHEMBL21783935

SCHEMBL21783935

CNC(=O)c1cc(F)c(N)c(F)c1

nearest known ligand 0.68

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HDAC6 Q9UBN7 6/20 0.68
HDAC1 Q13547 4/20 0.68
GAA P10253 1/20 0.42
HDAC8 Q9BY41 2/20 0.42
HDAC2 Q92769 1/20 0.42
PLAU P00749 1/20 0.41
CA2 P00918 1/20 0.40
HPGD P15428 2/20 0.39
TSHR P16473 1/20 0.39
HTT P42858 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
RPS6KA3 P51812 1/20 0.39
MAP4K4 O95819 1/20 0.39
ALDH1A1 P00352 1/20 0.39
PLK1 P53350 3/20 0.38
IKBKB O14920 1/20 0.38
THRB P10828 1/20 0.38
KIF11 P52732 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7981473 0.83 CES2 (0.56) HDAC6HDAC1GAAHDAC8HDAC2
SCHEMBL1004064 0.81 HDAC6 (0.70) HDAC6HDAC1GAAHDAC8HDAC2
SCHEMBL355600 0.79 HDAC6 (0.71) HDAC6HDAC1GAAHDAC8HDAC2
SCHEMBL15495188 0.78 GAA (0.48) HDAC6HDAC1GAAHDAC8HDAC2
SCHEMBL38657509 0.78 HDAC1 (0.47) HDAC6HDAC1GAAHDAC8HDAC2
SCHEMBL29055361 0.78 HDAC6 (0.46) HDAC6HDAC1GAAHDAC8HDAC2
SCHEMBL1005961 0.77 HDAC6 (0.43) HDAC6HDAC1HDAC8HDAC2PLAU
SCHEMBL4478521 0.77 HDAC8 (0.60) HDAC6HDAC8HDAC2PLAUCA2
SCHEMBL23183311 0.76 HDAC6 (0.58) HDAC6HDAC1GAAHDAC8HDAC2
SCHEMBL1002234 0.76 HDAC6 (0.44) HDAC6HDAC1GAAHDAC8HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230039917-A1 EXO-AZA SPIRO INHIBITORS OF MENIN-MLL INTERACTION JANSSEN PHARMACEUTICA NV (BE) 2023-02-09 US disclosed
US-10703080-B2 Film for medicine packaging and method of preparing the same Sichuan Huili Industry Co., Ltd. (CN) 2020-07-07 US disclosed
US-10703835-B2 Hyperbranched cationic mussel-imitated polymer and method of preparing the same Sichuan Huili Industry Co., Ltd. (CN) 2020-07-07 US disclosed
US-20200070485-A1 FILM FOR MEDICINE PACKAGING AND METHOD OF PREPARING THE SAME Sichuan Huili Industry Co., Ltd. (CN) 2020-03-05 US disclosed
US-20200071433-A1 HYPERBRANCHED CATIONIC MUSSEL-IMITATED POLYMER AND METHOD OF PREPARING THE SAME Sichuan Huili Industry Co., Ltd. (CN) 2020-03-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230039917-A1 EXO-AZA SPIRO INHIBITORS OF MENIN-MLL INTERACTION BMI1, MLLT1, SUZ12 HDAC6 915/4885HDAC1 245/4885GAA 3501/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.